Peer-reviewed articles

O’Connor M, O’Leary E, Waller J, et al. Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening. Prev Med. 2018;115:90-96. doi:10.1016/j.ypmed.2018.08.017

Donnelly DW, Donnelly C, Kearney T, et al. Urinary, bowel and sexual health in older men from Northern Ireland. BJU Int. 2018;122(5):845-857. doi:10.1111/bju.14182

Flanagan M, Solon J, Chang KH, et al. Peritoneal metastases from extra-abdominal cancer - A population-based study. Eur J Surg Oncol. 2018;44(11):1811-1817. doi:10.1016/j.ejso.2018.07.049

O’Brien KM, Mooney T, Fitzpatrick P, Sharp L. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis. Breast Cancer Res Treat. 2018;172(1):133-142. doi:10.1007/s10549-018-4877-9

Gatta G, Trama A, Capocaccia R, RARECARENet Working Group. Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. 2019;45(1):3-11. doi:10.1016/j.ejso.2017.08.018

Imbimbo M, Maury JM, Garassino M, Girard N. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Eur J Surg Oncol. 2019;45(1):75-80. doi:10.1016/j.ejso.2018.01.078

Lykoudis PM, Partelli S, Muffatti F, et al. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. European Journal of Surgical Oncology. 2019;45(1):46-51. doi:10.1016/j.ejso.2017.08.019

Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Eur J Surg Oncol. 2019;45(1):60-66. doi:10.1016/j.ejso.2018.02.006

Orlandi E, Alfieri S, Simon C, Trama A, Licitra L. Treatment challenges in and outside a network setting: Head and neck cancers. Eur J Surg Oncol. 2019;45(1):40-45. doi:10.1016/j.ejso.2018.02.007

Pasquali S, Bonvalot S, Tzanis D, et al. Treatment challenges in and outside a network setting: Soft tissue sarcomas. European Journal of Surgical Oncology. 2019;45(1):31-39. doi:10.1016/j.ejso.2017.09.015

Ray-Coquard I, Trama A, Seckl MJ, et al. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. European Journal of Surgical Oncology. 2019;45(1):67-74. doi:10.1016/j.ejso.2017.09.025

Dunne S, Coffey L, Sharp L, et al. Integrating self-management into daily life following primary treatment: head and neck cancer survivors’ perspectives. J Cancer Surviv. 2019;13(1):43-55. doi:10.1007/s11764-018-0726-4

Doherty AM, Lorenz L, Jabbar F, O’Leary E, Casey P. Sleep Disturbance in Adjustment Disorder and Depressive Episode. Int J Environ Res Public Health. 2019;16(6). doi:10.3390/ijerph16061083

Dunne S, Coffey L, Sharp L, et al. Investigating the impact of self-management behaviours on quality of life and fear of recurrence in head and neck cancer survivors: A population-based survey. Psychooncology. 2019;28(4):742-749. doi:10.1002/pon.5010

Gomez-Rubio P, Piñero J, Molina-Montes E, et al. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Int J Cancer. 2019;144(7):1540-1549. doi:10.1002/ijc.31866

Sexton DJ, O’Kelly P, O’Leary E, et al. Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants. JAMA Dermatol. 2019;155(5):594-598. doi:10.1001/jamadermatol.2018.4660

Donnelly C, Hart N, McCrorie AD, et al. Predictors of an early death in patients diagnosed with colon cancer: a retrospective case-control study in the UK. BMJ Open. 2019;9(6):e026057. doi:10.1136/bmjopen-2018-026057

Araghi M, Soerjomataram I, Bardot A, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4(7):511-518. doi:10.1016/S2468-1253(19)30147-5

Gatta G, Botta L, Comber H, et al. The European study on centralisation of childhood cancer treatment. Eur J Cancer. 2019;115:120-127. doi:10.1016/j.ejca.2019.04.024

O’Neill JP, Sexton DJ, O’Leary E, et al. Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group. Clin Transplant. 2019;33(10):e13669. doi:10.1111/ctr.13669

Quigley C, Deady S, Hughes E, McElnea E, Zgaga L, Chetty S. National incidence of eyelid cancer in Ireland (2005-2015). Eye (Lond). 2019;33(10):1534-1539. doi:10.1038/s41433-019-0437-8

Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493-1505. doi:10.1016/S1470-2045(19)30456-5

Menzies S, O’Leary E, Callaghan G, et al. Declining incidence of keratinocyte carcinoma in organ transplant recipients. Br J Dermatol. 2019;181(5):983-991. doi:10.1111/bjd.18094

Keeling E, Murray SL, Williams Y, et al. Merkel cell carcinoma in kidney transplant recipients in Ireland 1964-2018. Br J Dermatol. 2019;181(6):1314-1315. doi:10.1111/bjd.18218

O’Donovan B, Rodgers RM, Cox AR, Krska J. Use of information sources regarding medicine side effects among the general population: a cross-sectional survey. Prim Health Care Res Dev. 2019;20:e153. doi:10.1017/S1463423619000574